This video interview was created by ESO’s media partner Oruen.


ESO continues to update our curated collection of resources relevant for the treatment of stroke during the COVID-19 global pandemic.  We hope you will find this page valuable. #StrokeStillMatters

As further publications and studies emerge, this resource continues to grow. Please check back at the end of each month for the most recent publications. We encourage submissions of COVID-19 resources to be considered for inclusion. Please send the source and link to

Stroke and COVID-19

European Stroke Organisation interim expert opinion on cerebral venous thrombosis occurring after SARS-CoV-2 vaccination

Severe cases of cerebral venous thrombosis (CVT) with thrombocytopenia and anti-platelet factor 4 (PF4) antibodies occurring after adenoviral vector anti-SARS-CoV-2 vaccines have been recently reported. We aim to present a guidance document on the diagnosis and treatment of patients presenting with CVT after vaccination against SARS-CoV-2 infection. We reviewed the available evidence which consists on case reports, small case series, expert opinion and analogy with heparin-induced thrombocytopenia (HIT) management. Because of the low level of evidence, this is an interim document, based only on expert opinion consensus.

Publications Relevant for Stroke Diagnosis and Management

COVID-19 Vaccination and Cerebrovascular Events

Publications on COVID-19 and Stroke

The collected publications have been suggested by members of the Paper of the Month working group. ESO members can also nominate a paper for inclusion in this resource.